RU2056417C1 - Производные бензодиоксана - Google Patents

Производные бензодиоксана Download PDF

Info

Publication number
RU2056417C1
RU2056417C1 SU925011900A SU5011900A RU2056417C1 RU 2056417 C1 RU2056417 C1 RU 2056417C1 SU 925011900 A SU925011900 A SU 925011900A SU 5011900 A SU5011900 A SU 5011900A RU 2056417 C1 RU2056417 C1 RU 2056417C1
Authority
RU
Russia
Prior art keywords
dihydro
benzodioxin
mmol
methanamine
vacuo
Prior art date
Application number
SU925011900A
Other languages
English (en)
Russian (ru)
Inventor
Пол Стэк Гари
Абдель-Меджид Эбау-Харбиа Маджид
Гарольд Эндри Терранс
Тереза Шерер Норин
Original Assignee
Американ Хоум Продактс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/719,887 external-priority patent/US5126366A/en
Priority claimed from US07/719,882 external-priority patent/US5166367A/en
Application filed by Американ Хоум Продактс Корпорейшн filed Critical Американ Хоум Продактс Корпорейшн
Application granted granted Critical
Publication of RU2056417C1 publication Critical patent/RU2056417C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Insulators (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Light Receiving Elements (AREA)
SU925011900A 1991-06-21 1992-06-19 Производные бензодиоксана RU2056417C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/719,887 US5126366A (en) 1991-06-21 1991-06-21 Aminophenoxyalkyl derivatives of benzodioxan
US07/719,882 US5166367A (en) 1991-06-21 1991-06-21 Antipsychotic benzodioxan derivatives
US719882 1991-06-21
US719887 1991-06-21

Publications (1)

Publication Number Publication Date
RU2056417C1 true RU2056417C1 (ru) 1996-03-20

Family

ID=27110156

Family Applications (1)

Application Number Title Priority Date Filing Date
SU925011900A RU2056417C1 (ru) 1991-06-21 1992-06-19 Производные бензодиоксана

Country Status (19)

Country Link
EP (1) EP0520674B1 (enExample)
JP (1) JP3095533B2 (enExample)
KR (1) KR930000496A (enExample)
AT (1) ATE126515T1 (enExample)
AU (1) AU644743B2 (enExample)
BR (1) BR9202321A (enExample)
CZ (1) CZ281049B6 (enExample)
DE (1) DE69204117T2 (enExample)
DK (1) DK0520674T3 (enExample)
ES (1) ES2076691T3 (enExample)
FI (1) FI922880L (enExample)
GR (1) GR3018111T3 (enExample)
HU (1) HUT61739A (enExample)
IL (1) IL102137A (enExample)
MX (1) MX9203109A (enExample)
NZ (1) NZ243194A (enExample)
PH (1) PH30817A (enExample)
RU (1) RU2056417C1 (enExample)
TW (1) TW203047B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
KR102021281B1 (ko) * 2018-05-25 2019-09-16 한국 한의학 연구원 프락신을 유효성분으로 포함하는 우울증 및 불안장애 예방, 개선 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100960A (en) 1963-06-20 1968-01-31 Ward Blenkinsop & Co Ltd 1,4-benzodioxane derivatives
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Европейский патент N 170213, кл. C 07D 401/12, опублик. 1986. 2. Европейский патент N 236930, кл. C 07D 275/06, опублик. 1987. 3. Европейский патент N 175541, кл. C 07D 311/06, опублик. 1986. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого

Also Published As

Publication number Publication date
FI922880A0 (fi) 1992-06-18
JPH05194481A (ja) 1993-08-03
DE69204117D1 (de) 1995-09-21
TW203047B (enExample) 1993-04-01
EP0520674B1 (en) 1995-08-16
DE69204117T2 (de) 1996-03-14
FI922880A7 (fi) 1992-12-22
JP3095533B2 (ja) 2000-10-03
CZ182392A3 (en) 1993-01-13
FI922880L (fi) 1992-12-22
MX9203109A (es) 1993-06-01
CZ281049B6 (cs) 1996-06-12
BR9202321A (pt) 1993-01-19
PH30817A (en) 1997-10-17
KR930000496A (ko) 1993-01-15
DK0520674T3 (da) 1996-01-08
IL102137A0 (en) 1993-01-14
IL102137A (en) 1996-07-23
HUT61739A (en) 1993-03-01
GR3018111T3 (en) 1996-02-29
AU1842692A (en) 1992-12-24
AU644743B2 (en) 1993-12-16
EP0520674A1 (en) 1992-12-30
ES2076691T3 (es) 1995-11-01
HU9202060D0 (en) 1992-09-28
NZ243194A (en) 1993-10-26
ATE126515T1 (de) 1995-09-15

Similar Documents

Publication Publication Date Title
RU2178416C2 (ru) Аминометил-2,3,8,9-тетрагидро-7h-1,4-диоксино[2,3-е]-индол-8-оновые соединения и способ лечения
CZ20012657A3 (cs) Piperidinové, tetrahydropyridinové a piperazinové deriváty
CA2076948C (en) Isatineoxime derivatives, their preparation and use
Chapleo et al. Heteroaromatic analogs of the. alpha. 2-adrenoreceptor partial agonist clonidine
US5126366A (en) Aminophenoxyalkyl derivatives of benzodioxan
US5166367A (en) Antipsychotic benzodioxan derivatives
US5134140A (en) Psychotropic benzofuran derivatives
JP3253077B2 (ja) ヒドロイソキノリン誘導体
EP0162593B1 (en) Heterocyclic amino compounds
US5189171A (en) Antipsychotic benzodioxan derivatives
US5245051A (en) Antipsychotic chroman derivatives of benzodioxanmethylamine
JP3095533B2 (ja) 抗精神病剤用ベンゾジオキサン誘導体
AU780027B2 (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
US5235055A (en) Antipsychotic quinoline derivatives of benzodioxanmethylamine
JPH06102659B2 (ja) 新規ビス（アリール）アルケン誘導体、それらの製造法ならびにそれらを含有する医薬品組成物
HARADA et al. Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-chlorobenzamide derivatives
JPH0733744A (ja) インダゾール誘導体およびその塩
AU6289000A (en) Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
EP0162592B1 (en) Heterocyclic amino compounds
IE921946A1 (en) Antipsychotic benzodioxan derivatives
HU204821B (en) Process for producing endo-n-braces open brackets open (8-methyl-8-azabicyclo/3,2,1/octan-3/yl)-amino brackets closed -carbonyl braces closed-2-(cyclopropylmethoxy)-benzamide, its salts and pharmaceutical compositions comprising such compounds as active ingredient
US5182292A (en) Psychotropic piperidinylmethyl benzodioxans
US5221745A (en) Psychotropic piperidinylmethyl benzodioxans
US5212170A (en) Psychotropic piperidinylmethyl benzodioxans
JP2004537556A (ja) 抗精神病活性を有する２−（アミノメチル）−テトラヒドロ−９−オキサ−１，３−ジアザ−シクロペンタ［ａ］ナフタレニル誘導体